Lintuzumab-Ac225 in Older Acute Myeloid Leukemia (AML) Patients
Clinical trial NCT02575963 · COMPLETED
Trial details
- NCT number
- NCT02575963
- Sponsor
- Actinium Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2018-11-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.